RxDoctor Payments Data

Charles Bush

Vascular Surgery · Louisville, KYNPI 1619361680

Payments from drug & device makers

What this record shows

This record is dominated by grants: $5,000 of the $8,238 with a category attached, or 60.7%. Medtronic accounts for 76.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2020 at $5,216 and has fallen 80.4% since, to $1,025 in 2025. That places this record below the midpoint for vascular surgery clinicians in KY, where the typical reported total is $9,151.

$8,238in general payments, 2019–2025

Across 47 payments — averaging $175.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Integra Lifesciences Corporation$422
  • Silk Road Medical, Inc.$327
  • Endologix LLC$314
  • BD$170
  • Argon Medical Devices, Inc.$162
  • plus $525 from 15 others

What the payments were for

  • Grants$5,00061%
  • Travel & lodging$4485%
  • Food & beverage$2,05725%
  • Education$3284%
  • Other$4055%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,238 in reported general payments places this provider in the 45th percentile of 72 vascular surgery providers in Kentucky.

See all vascular surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$185,750
Medicare patients
871
Services billed
1,750

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$17,970
Cilostazol38$471
Atorvastatin Calcium44$316
Oxycodone Hcl73$254
ClopidogrelClopidogrel Bisulfate54$163
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$99

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →